Health
Regeneron suspends COVID-19 antibody trial among sickest patients – Gulf News
Move follows recommendation from independent committee which assesses results
A Regeneron Pharmaceuticals scientist works in the company’s Infectious disease lab in New York state on an experimental coronavirus antibody drug.
Image Credit: Regeneron / via AP file
Washington: US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its COVID-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the…
-
General14 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General19 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News19 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Noosa News24 hours agoQueensland government to set up $400m energy investment fund